News: Insmed Inc (INSM.OQ)
INSM.OQ on NASDAQ Stock Exchange Capital Market
10.69USD
1 Aug 2013
10.69USD
1 Aug 2013
Price Change (% chg)
$-0.42 (-3.78%)
$-0.42 (-3.78%)
Prev Close
$11.11
$11.11
Open
$11.20
$11.20
Day's High
$11.20
$11.20
Day's Low
$10.64
$10.64
Volume
103,692
103,692
Avg. Vol
162,816
162,816
52-wk High
$14.30
$14.30
52-wk Low
$2.86
$2.86
Select another date:
Mon, Jul 1 2013
UPDATE 2-Insmed's lung infection drug fares no better than rival, shares fall
* Drug shows smaller improvement in lung capacity vs rival
Insmed's lung infection drug succeeds in late-stage trial
July 1 - Insmed Inc said a late-stage trial of its experimental lung infection drug showed the therapy was as effective as another approved treatment.
Select another date:
Press Releases
- Insmed to Present at 31st Annual J.P. Morgan Healthcare Conference
- Insmed Announces CLEAR-108 Phase 3 Clinical Study of ARIKACEĀ® in Cystic Fibrosis Patients with Pseudomonas Lung Infections Has Completed Target Enrollment
- Insmed To Present At Two Upcoming Investor Conferences
- Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2012
- Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer
- Insmed to Host 2012 Third Quarter Earnings Conference Call
- NuPathe Announces Closing of $28 Million Private Placement and Changes to Its Board of Directors
- Insmed Announces Pricing of Approximately $26 Million Direct Public Offering
- Insmed Appoints Will Lewis as President and Chief Executive Officer
- Insmed to Present at Stifel Nicolaus 2012 Healthcare Conference

